Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

NCT02784756 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Viraemia

Interventions

DEVICE: Quantiferon-CMV assay

Sponsor

University Health Network, Toronto

Collaborators

[object Object]